China Resources Medical Holdings Company Stock | 1515.HK | KYG2133W1087 | A2DHMW

Date	China Resources Medical Holdings Company Price
11/15/2024	3.64 undefined
11/14/2024	3.62 undefined
11/13/2024	3.75 undefined
11/12/2024	3.84 undefined
11/11/2024	3.83 undefined
11/8/2024	3.86 undefined
11/7/2024	3.92 undefined
11/6/2024	3.81 undefined
11/5/2024	3.84 undefined
11/4/2024	3.76 undefined
11/1/2024	3.62 undefined
10/31/2024	3.56 undefined
10/30/2024	3.54 undefined
10/29/2024	3.57 undefined
10/28/2024	3.58 undefined
10/25/2024	3.48 undefined
10/24/2024	3.44 undefined
10/23/2024	3.58 undefined
10/22/2024	3.54 undefined
10/21/2024	3.49 undefined

Date	China Resources Medical Holdings Company Revenue	China Resources Medical Holdings Company EBIT	China Resources Medical Holdings Company Net Income
2026e	11.43 B undefined	1.3 B undefined	942.19 M undefined
2025e	11.09 B undefined	1.21 B undefined	838.37 M undefined
2024e	10.61 B undefined	1.09 B undefined	752.17 M undefined
2023	10.11 B undefined	1.02 B undefined	257.68 M undefined
2022	7.9 B undefined	593.7 M undefined	265.86 M undefined
2021	4.45 B undefined	354.33 M undefined	417.92 M undefined
2020	2.75 B undefined	300.37 M undefined	310.13 M undefined
2019	2.12 B undefined	516.91 M undefined	390.87 M undefined
2018	2.06 B undefined	537.35 M undefined	430.9 M undefined
2017	1.88 B undefined	460.93 M undefined	421.03 M undefined
2016	1.53 B undefined	289.12 M undefined	-1.51 B undefined
2015	1.37 B undefined	230.19 M undefined	167.05 M undefined
2014	1.21 B undefined	256.29 M undefined	230.05 M undefined
2013	887.4 M undefined	199.1 M undefined	90 M undefined
2012	758 M undefined	164.6 M undefined	101.1 M undefined
2011	509.5 M undefined	90.9 M undefined	48.1 M undefined
2010	394.1 M undefined	67.5 M undefined	42.8 M undefined

	Revenue	EBIT	Net Income
2010	394.1 M CNY	67.5 M CNY	42.8 M CNY
2011	509.5 M CNY	90.9 M CNY	48.1 M CNY
2012	758 M CNY	164.6 M CNY	101.1 M CNY
2013	887.4 M CNY	199.1 M CNY	90 M CNY
2014	1.21 B CNY	256.29 M CNY	230.05 M CNY
2015	1.37 B CNY	230.19 M CNY	167.05 M CNY
2016	1.53 B CNY	289.12 M CNY	-1.51 B CNY
2017	1.88 B CNY	460.93 M CNY	421.03 M CNY
2018	2.06 B CNY	537.35 M CNY	430.9 M CNY
2019	2.12 B CNY	516.91 M CNY	390.87 M CNY
2020	2.75 B CNY	300.37 M CNY	310.13 M CNY
2021	4.45 B CNY	354.33 M CNY	417.92 M CNY
2022	7.9 B CNY	593.7 M CNY	265.86 M CNY
2023	10.11 B CNY	1.02 B CNY	257.68 M CNY
2024e	10.61 B CNY	1.09 B CNY	752.17 M CNY
2025e	11.09 B CNY	1.21 B CNY	838.37 M CNY
2026e	11.43 B CNY	1.3 B CNY	942.19 M CNY

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.39	0.51	0.76	0.89	1.21	1.37	1.53	1.88	2.06	2.12	2.75	4.45	7.9	10.11	10.61	11.09	11.43
-	29.19	48.92	17.02	35.96	13.76	11.66	22.52	9.70	2.72	30.02	61.71	77.67	27.92	4.97	4.53	3.07
23.35	23.97	24.27	23.90	24.63	23.98	26.50	35.59	36.72	36.03	23.13	20.98	16.52	18.85	17.96	17.18	16.67
0.09	0.12	0.18	0.21	0.3	0.33	0.41	0.67	0.76	0.76	0.64	0.93	1.31	1.91	0	0	0
42	48	101	90	230	167	-1,506	421	430	390	310	417	265	257	752	838	942
-	14.29	110.42	-10.89	155.56	-27.39	-1,001.80	-127.95	2.14	-9.30	-20.51	34.52	-36.45	-3.02	192.61	11.44	12.41
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.6	0.6	0.6	0.58	0.83	0.82	0.9	1.28	1.27	1.25	1.26	1.26	1.26	1.26	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022

0.32	0.35	0.17	1.28	1.07	1.01	1.19	1.59	1.9	2.28	2.97	2.64	3.42
0.02	0.02	0.08	0.08	0.09	0.14	0.26	0.35	0.51	0.63	0.64	0.79	1.51
0.04	0.08	0.06	0.07	0.08	0.07	0.13	0.1	0.02	0.21	0.29	0.17	1.06
22.3	23.2	35.1	31.1	33.83	42.32	50.24	38.6	77.89	62.12	142.04	185.08	367.48
3.1	8.9	10.1	10.3	15.69	27.23	25.24	27.46	29.46	19.59	102.89	141.26	399.51
0.41	0.49	0.37	1.47	1.29	1.29	1.65	2.11	2.53	3.2	4.15	3.92	6.77
0.09	0.11	0.12	0.12	0.14	0.15	0.26	0.26	0.26	0.34	1.05	2.12	5.42
0	0	0	0	0	0.15	0.68	0.67	0.67	0.63	0.75	1.93	1.57
22.3	36.1	48.5	51.2	68.99	109.42	113	160.88	161.66	136.04	128.41	58.9	60.25
0.11	0.16	0.32	0.32	0.36	0.4	2.13	2.11	2.1	2.04	1.35	0.08	0.07
0	0	0	0	0	0	1.46	1.46	1.46	1.46	1.47	2.28	3.74
31.2	346.1	162.5	158.9	151.79	147.4	143.72	140.35	136.97	76.27	76.46	86.45	191.86
0.25	0.64	0.66	0.65	0.72	0.96	4.79	4.8	4.79	4.68	4.82	6.54	11.05
0.66	1.13	1.02	2.12	2.01	2.26	6.45	6.91	7.32	7.87	8.96	10.47	17.82

130.6	165.6	140.6	0.2	0.17	0.17	0.27	0.27	0.27	0.27	0.27	0.27	0.27
0	0	0	1.54	1.5	1.38	6.37	6.3	6.18	5.99	5.88	5.79	0
0.15	0.43	0.34	0.07	0.3	0.5	-1.01	-0.6	-0.19	0.21	0.53	0.96	9.51
0	0	0	0	0	6.76	16.98	-0.54	-15.7	-17.03	-21.27	-14.66	0
0	0	0	0	0	0	-16.27	-16.27	0	0	0	0	0
0.28	0.59	0.49	1.62	1.8	1.89	5.35	5.68	5.97	6.19	6.39	6.73	9.51
0.08	0.09	0.12	0.12	0.17	0.21	0.24	0.26	0.22	0.24	0.56	0.83	1.73
10.3	13.1	18.8	17.8	17.06	23.15	59.18	92.17	106.24	106.39	279.03	435.53	0
0.06	0.03	0.05	0.06	0.08	0.16	0.45	0.46	0.46	0.45	0.66	0.49	2.04
0	0	0	0	0	0	0	0.17	0.49	0.58	0.68	1.67	0
0	0.2	0.01	0.2	0	0	0	0	0	0.01	0.02	0.02	1.35
0.14	0.33	0.2	0.4	0.27	0.39	0.75	0.98	1.28	1.38	2.21	3.44	5.12
0.2	0	0.23	0	0	0	0	0	0	0.01	0.05	0.04	1.05
0	0	0	0	0	0	318.88	317.63	316.37	317.83	317.62	95.25	71.32
12.6	10.5	8.6	5.3	3.23	2.92	19.58	18.39	16.02	18.12	51.16	41.92	915.48
0.21	0.01	0.24	0.01	0	0	0.34	0.34	0.33	0.35	0.42	0.18	2.04
0.36	0.34	0.44	0.41	0.28	0.39	1.09	1.31	1.61	1.73	2.62	3.62	7.16
0.64	0.93	0.93	2.03	2.08	2.28	6.44	6.99	7.58	7.92	9.01	10.35	16.67

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
65	78	147	143	316	247	-1,452	559	588	541	418	270	242
17	17	32	33	35	41	47	63	69	63	113	182	332
0	0	0	0	0	0	0	0	0	0	0	0	0
-14	-48	-33	-41	-34	-86	-107	-76	-276	-226	211	40	-111
0	0.01	0.02	0.04	-0.04	0.03	1.74	-0.09	-0.05	-0.01	-0.1	0.22	0.16
0	18	23	32	0	0	0	1	6	16	14	19	46
11	20	27	41	59	80	71	60	162	163	98	135	135
70	62	166	169	274	231	223	459	334	366	643	710	626
-17	-34	-28	-21	-36	-32	-42	-34	-57	-36	-209	-227	-252
-328	-36	-102	-841	360	29	120	-545	355	157	60	-1,936	57
-310	-1	-74	-820	397	61	162	-510	413	193	269	-1,708	310
0	0	0	0	0	0	0	0	0	0	0	0	0
200	0	32	-41	0	0	0	180	303	73	131	966	143
0	0	-0.2	1.39	-0.18	-0.02	0	-0.1	-0.21	0	0	0	0
298	230	-282	971	-421	-48	-98	-104	-44	-40	-7	845	-33
98	230	-114	-379	-1	7	-15	-112	-15	17	-23	-29	-47
0	0	0	0	-44	-32	-83	-69	-118	-131	-115	-91	-129
40	256	-217	288	209	210	247	-192	647	482	695	-377	653
52.9	28.1	138.3	148.4	237.96	199.53	181.34	425.04	276.54	329.69	434.14	483.17	373.72
0	0	0	0	0	0	0	0	0	0	0	0	0

China Resources Medical Holdings Company Gross margin	China Resources Medical Holdings Company Profit margin	China Resources Medical Holdings Company EBIT margin	China Resources Medical Holdings Company Profit margin
2026e	18.86 %	11.34 %	8.24 %
2025e	18.86 %	10.87 %	7.56 %
2024e	18.86 %	10.3 %	7.09 %
2023	18.86 %	10.12 %	2.55 %
2022	16.53 %	7.51 %	3.36 %
2021	20.99 %	7.97 %	9.4 %
2020	23.14 %	10.92 %	11.27 %
2019	36.04 %	24.44 %	18.48 %
2018	36.74 %	26.09 %	20.92 %
2017	35.59 %	24.55 %	22.42 %
2016	26.53 %	18.86 %	-98.31 %
2015	24.02 %	16.77 %	12.17 %
2014	24.68 %	21.25 %	19.07 %
2013	23.97 %	22.44 %	10.14 %
2012	24.38 %	21.72 %	13.34 %
2011	24.08 %	17.84 %	9.44 %
2010	23.57 %	17.13 %	10.86 %

	Gross margin	EBIT margin	Profit margin
2010	23.57 %	17.13 %	10.86 %
2011	24.08 %	17.84 %	9.44 %
2012	24.38 %	21.72 %	13.34 %
2013	23.97 %	22.44 %	10.14 %
2014	24.68 %	21.25 %	19.07 %
2015	24.02 %	16.77 %	12.17 %
2016	26.53 %	18.86 %	-98.31 %
2017	35.59 %	24.55 %	22.42 %
2018	36.74 %	26.09 %	20.92 %
2019	36.04 %	24.44 %	18.48 %
2020	23.14 %	10.92 %	11.27 %
2021	20.99 %	7.97 %	9.4 %
2022	16.53 %	7.51 %	3.36 %
2023	18.86 %	10.12 %	2.55 %
2024e	18.86 %	10.3 %	7.09 %
2025e	18.86 %	10.87 %	7.56 %
2026e	18.86 %	11.34 %	8.24 %

Date	China Resources Medical Holdings Company Sales per Share	China Resources Medical Holdings Company EBIT per share	China Resources Medical Holdings Company Earnings per Share
2026e	8.87 undefined	0 undefined	0.73 undefined
2025e	8.61 undefined	0 undefined	0.65 undefined
2024e	8.23 undefined	0 undefined	0.58 undefined
2023	7.99 undefined	0.81 undefined	0.2 undefined
2022	6.26 undefined	0.47 undefined	0.21 undefined
2021	3.52 undefined	0.28 undefined	0.33 undefined
2020	2.18 undefined	0.24 undefined	0.25 undefined
2019	1.69 undefined	0.41 undefined	0.31 undefined
2018	1.62 undefined	0.42 undefined	0.34 undefined
2017	1.47 undefined	0.36 undefined	0.33 undefined
2016	1.7 undefined	0.32 undefined	-1.67 undefined
2015	1.67 undefined	0.28 undefined	0.2 undefined
2014	1.45 undefined	0.31 undefined	0.28 undefined
2013	1.54 undefined	0.35 undefined	0.16 undefined
2012	1.26 undefined	0.27 undefined	0.17 undefined
2011	0.85 undefined	0.15 undefined	0.08 undefined
2010	0.65 undefined	0.11 undefined	0.07 undefined

	Sales per Share	EBIT per share	Earnings per Share
2010	0.65 CNY	0.11 CNY	0.07 CNY
2011	0.85 CNY	0.15 CNY	0.08 CNY
2012	1.26 CNY	0.27 CNY	0.17 CNY
2013	1.54 CNY	0.35 CNY	0.16 CNY
2014	1.45 CNY	0.31 CNY	0.28 CNY
2015	1.67 CNY	0.28 CNY	0.2 CNY
2016	1.7 CNY	0.32 CNY	-1.67 CNY
2017	1.47 CNY	0.36 CNY	0.33 CNY
2018	1.62 CNY	0.42 CNY	0.34 CNY
2019	1.69 CNY	0.41 CNY	0.31 CNY
2020	2.18 CNY	0.24 CNY	0.25 CNY
2021	3.52 CNY	0.28 CNY	0.33 CNY
2022	6.26 CNY	0.47 CNY	0.21 CNY
2023	7.99 CNY	0.81 CNY	0.2 CNY
2024e	8.23 CNY	0 CNY	0.58 CNY
2025e	8.61 CNY	0 CNY	0.65 CNY
2026e	8.87 CNY	0 CNY	0.73 CNY

	Number of stocks
2010	602.7 M Aktien
2011	602.7 M Aktien
2012	602.7 M Aktien
2013	575.8 M Aktien
2014	830.87 M Aktien
2015	819.35 M Aktien
2016	901.56 M Aktien
2017	1.28 B Aktien
2018	1.27 B Aktien
2019	1.25 B Aktien
2020	1.26 B Aktien
2021	1.26 B Aktien
2022	1.26 B Aktien
2023	1.26 B Aktien
2024e	1.26 B Aktien
2025e	1.26 B Aktien
2026e	1.26 B Aktien

Date	China Resources Medical Holdings Company Dividend
2026e	0.04 undefined
2025e	0.04 undefined
2024e	0.04 undefined
2023	0.04 undefined
2022	0.12 undefined
2021	0.09 undefined
2020	0.1 undefined
2019	0.12 undefined
2018	0.11 undefined
2017	0.06 undefined
2016	0.12 undefined
2015	0.05 undefined
2014	0.07 undefined

	Dividend	Dividend (Estimate)
2010	0 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0.07 CNY	0 CNY
2015	0.05 CNY	0 CNY
2016	0.12 CNY	0 CNY
2017	0.06 CNY	0 CNY
2018	0.11 CNY	0 CNY
2019	0.12 CNY	0 CNY
2020	0.1 CNY	0 CNY
2021	0.09 CNY	0 CNY
2022	0.12 CNY	0 CNY
2023	0.04 CNY	0 CNY
2024e	0 CNY	0.04 CNY
2025e	0 CNY	0.04 CNY
2026e	0 CNY	0.04 CNY

Date	China Resources Medical Holdings Company Payout ratio
2026e	43.27 %
2025e	46.69 %
2024e	41.69 %
2023	41.43 %
2022	56.96 %
2021	26.67 %
2020	40.66 %
2019	38.52 %
2018	32.36 %
2017	19.16 %
2016	-7.18 %
2015	24.52 %
2014	24.2 %
2013	41.43 %
2012	41.43 %
2011	41.43 %
2010	41.43 %

	Payout ratio
2010	41.43 %
2011	41.43 %
2012	41.43 %
2013	41.43 %
2014	24.2 %
2015	24.52 %
2016	-7.18 %
2017	19.16 %
2018	32.36 %
2019	38.52 %
2020	40.66 %
2021	26.67 %
2022	56.96 %
2023	41.43 %
2024e	41.69 %
2025e	46.69 %
2026e	43.27 %

Date	EPS Estimate	EPS Actual	Quarterly report
12/31/2018	0.16	0.18 (10.29 %)	2018 Q4
6/30/2018	0.15	0.16 (4.58 %)	2018 Q2
6/30/2017	0.12	0.18 (47.88 %)	2017 Q2
6/30/2016	0.17	0.16 (-7.73 %)	2016 Q2
12/31/2015	0.17	0.17 (-4.84 %)	2015 Q4

%	Name	Stocks	Change	Date
36.81744 %	China Resources Co Ltd	474,319,516	0	12/31/2023
4.94695 %	First Sentier Investors (Hong Kong) Limited	63,731,666	-1,025,500	5/9/2024
4.70239 %	FIL Investment Management (Hong Kong) Limited	60,581,000	18,345,181	10/15/2024
4.12400 %	FIL Investment Management (Singapore) Ltd.	53,129,500	46,935,299	10/15/2024
3.42030 %	British Columbia Investment Management Corp.	44,063,720	5,307,078	3/31/2023
2.49619 %	Norges Bank Investment Management (NBIM)	32,158,500	-3,818,373	6/30/2024
1.98123 %	Fidelity International	25,524,251	-2,917	8/31/2024
1.45945 %	The Vanguard Group, Inc.	18,802,088	0	9/30/2024
1.43767 %	Dimensional Fund Advisors, L.P.	18,521,500	0	9/30/2024
1.10316 %	BlackRock Institutional Trust Company, N.A.	14,212,000	44,000	9/30/2024
1.04552 %	Bosera Asset Management Co., Ltd.	13,469,500	-48,500	6/30/2024
0.94667 %	China Merchants Fund Management Co. Ltd.	12,196,000	500	6/30/2024
0.32042 %	Caisse de Depot et Placement du Quebec	4,128,000	4,128,000	12/31/2023
0.31192 %	Huisheng Fund Management Co., Ltd.	4,018,500	0	6/30/2024
0.30179 %	Evli Fund Management Company Ltd.	3,888,000	3,888,000	6/30/2024
0.28976 %	BlackRock Advisors (UK) Limited	3,733,000	63,000	9/30/2024
0.27754 %	APG Asset Management N.V.	3,575,553	-1,264,210	12/31/2023
0.27734 %	American Century Investment Management, Inc.	3,573,000	0	7/31/2024
0.26989 %	APS Asset Management Pte. Ltd.	3,477,000	-41,000	6/30/2024
0.25099 %	California State Teachers Retirement System	3,233,500	58,500	6/30/2023
0.19988 %	Tianhong Asset Management Co., Ltd.	2,575,069	-4,188,931	6/30/2024
0.17077 %	BOCOM International Asset Management Limited	2,200,000	2,200,000	6/30/2023
0.16323 %	Florida State Board of Administration	2,102,900	315,700	6/30/2024
0.13776 %	Cheng (Libing)	1,774,746	0	2/27/2023
0.12241 %	Dimensional Fund Advisors, Ltd.	1,577,000	0	9/30/2024
0.10013 %	State Street Global Advisors (US)	1,290,000	-15,500	9/30/2024
0.09928 %	GF Fund Management Co., Ltd.	1,279,000	0	6/30/2024
0.08419 %	California Public Employees' Retirement System	1,084,588	-15,000	6/30/2023
0.05616 %	Nuveen LLC	723,500	0	7/31/2024
0.05391 %	First Sentier Investments (U.K.) Ltd	694,500	112,000	2/29/2024
0.04937 %	Asset Management One Co., Ltd.	636,000	611,500	11/30/2023
0.04627 %	Geode Capital Management, L.L.C.	596,132	11,632	8/31/2024
0.04599 %	BlackRock Fund Management Co., Ltd.	592,500	0	6/30/2024
0.04401 %	Mellon Investments Corporation	567,000	-16,500	9/30/2024
0.03105 %	Song (Qing)	400,000	0	12/31/2023
0.02387 %	DFA Australia Ltd.	307,525	27,212	8/31/2024
0.02329 %	Ren (Yuan)	300,000	0	6/13/2023
0.02232 %	Fidelity International Asset Management Company (Korea)	287,500	287,500	3/31/2024
0.02089 %	Allianz Global Investors GmbH	269,178	227	3/31/2024
0.01871 %	State Street Global Advisors Ireland Limited	241,000	0	9/30/2024
0.01785 %	Western Leadbank Fund Management Co., Ltd.	230,000	-2,000	6/30/2024
0.01781 %	Huatai-PineBridge Fund Management Co., Ltd.	229,500	-4,000	6/30/2024
0.01424 %	Penghua Fund Management Co., Ltd.	183,500	-851,500	6/30/2024
0.01265 %	Parametric Portfolio Associates LLC	163,000	0	7/31/2024
0.01246 %	Harvest Fund Management Co., Ltd.	160,500	160,500	12/31/2023
0.01087 %	FIL Investment Management (Australia) Limited	140,000	0	5/31/2024
0.00944 %	ASPOMA Asset Management GmbH	121,600	0	8/31/2024
0.00939 %	LSV Asset Management	121,000	0	6/30/2024
0.00551 %	Avantis Investors	71,000	-496,500	6/30/2024
0.00517 %	Vanguard Investments Australia Ltd.	66,625	-406	6/30/2024
0.00512 %	Ge (Lu)	66,000	0	12/31/2023
0.00446 %	Vanguard Global Advisers LLC	57,500	0	9/30/2024
0.00229 %	HSBC Global Asset Management (UK) Limited	29,543	0	9/30/2024
0.00225 %	E Fund Management Co. Ltd.	28,945	-1,518,750	6/30/2024
0.00147 %	Natixis Investment Managers SA	19,000	0	8/31/2023
0.00105 %	Irish Life Investment Managers Ltd.	13,500	0	9/30/2024
0.00078 %	Fullgoal Fund Management Co., Ltd.	10,000	-302,500	6/30/2024
0.00047 %	Mackenzie Investments	6,000	-760,699	3/31/2024
0.00019 %	Krane Funds Advisors, LLC	2,500	0	9/30/2023
0.00005 %	BMO Asset Management Inc.	660	0	11/30/2023
0.00004 %	CI Global Asset Management	534	-7	9/30/2024
0.00004 %	Truvalue Asset Management Co., Ltd.	500	-2,015,000	6/30/2024
0 %	Bank of Beijing Scotiabank Asset Management Co., Ltd.	0	-34,500	12/31/2023
0 %	Finlabo SIM S.p. A.	0	-50,000	2/29/2024
0 %	RAM Active Investments S.A.	0	-94,500	3/31/2024
0 %	Essence Fund Management Co., Ltd.	0	-137,000	6/30/2024
0 %	Ping An Fund Management Company Limited	0	-212,000	6/30/2024
0 %	Union Investment Luxembourg S.A.	0	-431,000	9/30/2023
0 %	Taikang Asset Management Co., Ltd.	0	-1,480,000	6/30/2024
0 %	CITIC Prudential Fund Management Co., Ltd.	0	-933,322	12/31/2023
0 %	CCB Principal Asset Management Co., Ltd.	0	-50,500	6/30/2024
0 %	JPMorgan Asset Management (China) Company Limited.	0	-854,500	6/30/2024
0 %	Everbright PGIM Fund Management Co., Ltd.	0	-474,000	12/31/2023
0 %	INVESCO Great Wall Fund Management Co. Ltd.	0	-62,000	6/30/2024
0 %	Yinhua Fund Management Co., Ltd.	0	-357,500	6/30/2024
0 %	HuaAn Fund Management Co., Ltd.	0	-1,203,500	12/31/2023
0 %	SEI Investments Management Corporation	0	-297,898	6/30/2023
0 %	Margetts Fund Management Limited	0	-85,500	6/30/2024
0 %	First Trust Advisors L.P.	0	-2,974,867	10/31/2023
0 %	Boston Partners	0	-136,500	5/31/2024
0 %	Segall Bryant & Hamill, LLC	0	-300,500	3/31/2024
0 %	First Sentier Investors (Singapore)	0	-58,000	6/30/2024
0 %	State Street Global Advisors (UK) Ltd.	0	-63,500	6/30/2024
0 %	BlackRock Investment Management (Australia) Ltd.	0	-2,500	1/31/2024
0 %	Allianz Global Investors Asia Pacific Limited	0	-134,500	5/31/2023
0 %	JPMorgan Asset Management U.K. Limited	0	-117,256	3/31/2024
0 %	PGGM Vermogensbeheer B.V.	0	-12,791,942	7/31/2023
0 %	Wilmington Trust Investment Management LLC	0	-21,000	9/30/2023
0 %	Wellington Management Company, LLP	0	-2,316,433	3/31/2024
0 %	Loomis, Sayles & Company, L.P.	0	-29,000	12/31/2023
0 %	Lazard Asset Management, L.L.C.	0	-98,000	7/31/2024
0 %	Bessemer Trust Company, N.A. (US)	0	-909,312	4/30/2024
0 %	Northern Trust Investments, Inc.	0	-24,500	12/31/2023
0 %	Numeric Investors LLC	0	-100,101	6/30/2024
0 %	PineStone Asset Management Inc.	0	-93,770	6/30/2023
0 %	Lundgreen's Capital ApS	0	-93,500	4/30/2024
0 %	Wu (Ting Yuk)	0	-1,000,000	5/17/2024

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
UMP Healthcare Holdings	SupplierCustomer	0,29	0,21	0,32	0,44	0,81	0,04
Mitsubishi UFJ Financial Group	SupplierCustomer	-0,31	-0,10	0,30	-0,48	-0,60	-0,14

What values and corporate philosophy does China Resources Medical Holdings Company represent?

China Resources Medical Holdings Company Ltd represents values and a corporate philosophy centered on the provision of high-quality medical services and the promotion of public health in China. The company is committed to delivering accessible, efficient, and patient-centric healthcare, aiming to enhance the overall well-being of individuals and communities. China Resources Medical Holdings Company Ltd prioritizes innovation, leveraging cutting-edge technology and medical advancements to elevate the standards of healthcare delivery. With a focus on professionalism, integrity, and transparency, the company is dedicated to fostering a culture of continuous improvement in the medical field.

In which countries and regions is China Resources Medical Holdings Company primarily present?

China Resources Medical Holdings Company Ltd (CRMH) primarily operates in the Asia-Pacific region, with a focused presence in China. As a leading integrated medical service provider, CRMH has established a strong foothold in various provinces and municipalities across Mainland China. Through its extensive network, CRMH delivers comprehensive healthcare services, including medical consultations, surgeries, diagnostics, and pharmaceutical products. With a commitment to enhancing the accessibility and quality of healthcare, CRMH continually expands its presence to better serve the growing healthcare needs of the Chinese population.

What significant milestones has the company China Resources Medical Holdings Company achieved?

China Resources Medical Holdings Company Ltd has achieved several significant milestones in recent years. The company has successfully expanded its presence in the healthcare sector, becoming one of the leading integrated medical service providers in China. China Resources Medical Holdings Company Ltd has also achieved remarkable growth in terms of revenue and market share. The company has made strategic acquisitions and partnerships to enhance its capabilities and broaden its service offerings. Furthermore, China Resources Medical Holdings Company Ltd has been recognized for its commitment to quality patient care, innovative technologies, and efficient healthcare delivery. Overall, the company has shown outstanding progress and stands as a prominent player in the Chinese medical industry.

What is the history and background of the company China Resources Medical Holdings Company?

China Resources Medical Holdings Company Ltd, also known as CR Medical, is a reputable healthcare service provider in China. Established in 2005, it is a subsidiary of China Resources Corporation, a Fortune Global 500 company. With a strong focus on both medical services and pharmaceutical products, CR Medical has grown into a leading integrated healthcare group. The company operates a vast network of hospitals, clinics, and pharmacies across the country, offering a wide range of medical specialties and healthcare services to patients. Committed to promoting accessible and high-quality healthcare, China Resources Medical Holdings Company Ltd continues to expand its reach and enhance the well-being of communities it serves.

Who are the main competitors of China Resources Medical Holdings Company in the market?

Some of the main competitors of China Resources Medical Holdings Company Ltd in the market include Beijing Gehua CATV Network Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., and Jiangsu Hengrui Medicine Co., Ltd.

In which industries is China Resources Medical Holdings Company primarily active?

China Resources Medical Holdings Company Ltd is primarily active in the healthcare industry.

What is the business model of China Resources Medical Holdings Company?

The business model of China Resources Medical Holdings Company Ltd focuses on providing comprehensive healthcare services in China. The company aims to offer a wide range of medical services, including hospital operations, the distribution of pharmaceutical and healthcare products, medical device manufacturing and sales, as well as healthcare management. China Resources Medical Holdings Company Ltd aims to establish a complete healthcare chain by integrating medical resources and promoting the development of high-quality healthcare services across the country. With its diverse healthcare offerings, the company strives to improve the overall well-being and medical care accessibility for individuals in China.

What is the P/E ratio of China Resources Medical Holdings Company 2024?

The China Resources Medical Holdings Company P/E ratio is 6.12.

What is the P/S ratio of China Resources Medical Holdings Company 2024?

The China Resources Medical Holdings Company P/S ratio is 0.43.

What is the Quality Investing of China Resources Medical Holdings Company?

The Quality Investing for China Resources Medical Holdings Company is 7/10.

What is the revenue of China Resources Medical Holdings Company 2024?

The expected China Resources Medical Holdings Company revenue is 10.61 B CNY.

How high is the profit of China Resources Medical Holdings Company 2024?

The expected China Resources Medical Holdings Company profit is 752.17 M CNY.

What is the business model of China Resources Medical Holdings Company

China Resources Medical Holdings Company Ltd is one of the leading companies in the healthcare sector in China. The company offers a wide range of medical services and products and is divided into several divisions. The divisions of China Resources Medical Holdings include hospitals, medical facilities, diagnostic centers, as well as the sale of pharmaceuticals and medical products. The company owns and operates several hospitals and medical facilities nationwide. These provide comprehensive care for various health issues and have state-of-the-art medical equipment and technologies. In addition, the company also offers specialized services in areas such as ophthalmology, plastic surgery, and geriatrics. Furthermore, China Resources Medical Holdings operates diagnostic centers that offer a complete range of diagnostic services for patients. These include ultrasound, endoscopy, magnetic resonance imaging, and computed tomography. The company is also involved in the sale of pharmaceuticals and medical products. It distributes a wide range of products, including generic drugs, over-the-counter products, and medical devices for use in hospitals and medical facilities. Additionally, they are engaged in pharmaceutical research and development and have a strong product pipeline in various therapy areas. The company also works closely with other companies to advance research and development of new therapies. Overall, the business model of China Resources Medical Holdings is focused on meeting the needs of patients by offering a complete range of products and services to improve their health and well-being. The company places special emphasis on the quality, safety, and effectiveness of its products and services and has an excellent reputation in the industry. Given the expanding healthcare sector in China, China Resources Medical Holdings is well positioned to continue growing and increasing its market share. The company will also continue to invest in research and development and introduce new products and services to meet consumer demands.

What is the China Resources Medical Holdings Company dividend?

China Resources Medical Holdings Company pays a dividend of 0.12 CNY distributed over payouts per year.

How often does China Resources Medical Holdings Company pay dividends?

The dividend cannot currently be calculated for China Resources Medical Holdings Company or the company does not pay out a dividend.

What is the China Resources Medical Holdings Company ISIN?

The ISIN of China Resources Medical Holdings Company is KYG2133W1087.

What is the China Resources Medical Holdings Company WKN?

The WKN of China Resources Medical Holdings Company is A2DHMW.

What is the China Resources Medical Holdings Company ticker?

The ticker of China Resources Medical Holdings Company is 1515.HK.

How much dividend does China Resources Medical Holdings Company pay?

Over the past 12 months, China Resources Medical Holdings Company paid a dividend of 0.04 CNY . This corresponds to a dividend yield of about 1.02 %. For the coming 12 months, China Resources Medical Holdings Company is expected to pay a dividend of 0.04 CNY.

What is the dividend yield of China Resources Medical Holdings Company?

The current dividend yield of China Resources Medical Holdings Company is 1.02 %.

When does China Resources Medical Holdings Company pay dividends?

China Resources Medical Holdings Company pays a quarterly dividend. This is distributed in the months of July, July, July, October.

How secure is the dividend of China Resources Medical Holdings Company?

China Resources Medical Holdings Company paid dividends every year for the past 13 years.

What is the dividend of China Resources Medical Holdings Company?

For the upcoming 12 months, dividends amounting to 0.04 CNY are expected. This corresponds to a dividend yield of 1.03 %.

In which sector is China Resources Medical Holdings Company located?

China Resources Medical Holdings Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Resources Medical Holdings Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Resources Medical Holdings Company from 10/25/2024 amounting to 0.055 CNY, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did China Resources Medical Holdings Company pay the last dividend?

The last dividend was paid out on 10/25/2024.

What was the dividend of China Resources Medical Holdings Company in the year 2023?

In the year 2023, China Resources Medical Holdings Company distributed 0.12 CNY as dividends.

In which currency does China Resources Medical Holdings Company pay out the dividend?

The dividends of China Resources Medical Holdings Company are distributed in CNY.

Stock Exchange	China Resources Medical Holdings Company Ticker
FRANKFURT	1PH.F
HKSE	1515.HK

China Resources Medical Holdings Company Ticker	China Resources Medical Holdings Company FIGI
1515:HK	BBG005L6RV12
1PH:GR	BBG005NJVS87
1PH:GF	BBG005NJVS96
1PH:GS	BBG005NJVSD1
1PH:TH	BBG00C3MM319
1515EUR:EO	BBG00CTTK3X3
1515EUR:XH	BBG00CTTK407
1515EUR:XF	BBG00CTTK425
1515EUR:XE	BBG00CTTK443
1515EUR:XJ	BBG00CTTK452
1515EUR:XL	BBG00CTTK461
1515EUR:XG	BBG00CTTK470
1515EUR:XO	BBG00CTTK489
1515EUR:XS	BBG00CTTK4D3
1515EUR:XA	BBG00CTTK4F1
1515EUR:E1	BBG00CTTK4G0
1515EUR:XT	BBG00CTTK4H9
1515EUR:XW	BBG00CTTK4J7
1515EUR:XU	BBG00CTTK4K5
1515EUR:XV	BBG00CTTK4L4
1515EUR:EU	BBG00CTTK4N2
1515:H2	BBG00F135N11
1515:H1	BBG00HMKF2K0
1515EUR:XX	BBG00JN8HDS8
1515N:PO	BBG00JRFTWR4
1515N:L3	BBG00JRG0WL9
1515N:B3	BBG00JRG46R6
1515HKD:X2	BBG00JRGFZW4
1515HKD:XB	BBG00JRGFZX3
1515HKD:XH	BBG00JRGFZZ1
1515HKD:XF	BBG00JRGG014
1515HKD:XE	BBG00JRGG032
1515HKD:XJ	BBG00JRGG041
1515HKD:XL	BBG00JRGG050
1515HKD:XG	BBG00JRGG069
1515HKD:XO	BBG00JRGG078
1515HKD:XS	BBG00JRGG0C2
1515HKD:XA	BBG00JRGG0D1
1515HKD:E1	BBG00JRGG0F9
1515HKD:XT	BBG00JRGG0G8
1515HKD:XW	BBG00JRGG0H7
1515HKD:XU	BBG00JRGG0J5
1515HKD:XV	BBG00JRGG0K3
1515HKD:XM	BBG00JRGG0L2
1515HKD:XQ	BBG00JRGG0N0
1515HKD:XX	BBG00JRGG0P8
1515HKD:XZ	BBG00JRGG0Q7
1515HKD:EU	BBG00JRGG0S5
1515N:L1	BBG00Y7B11S9
1PH:LA	BBG018H99V14
1PH:LU	BBG018J2YVV6

Access the world's leading financial data and tools

Price

Price

Ticker1515.HK

ISINKYG2133W1087

WKNA2DHMW

China Resources Medical Holdings Company stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

China Resources Medical Holdings Company Stock Price History

China Resources Medical Holdings Company Revenue, EBIT, Net Income KYG2133W1087 · A2DHMW

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

China Resources Medical Holdings Company Revenue, EBIT and net profit per share

China Resources Medical Holdings Company Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

China Resources Medical Holdings Company stock margins KYG2133W1087 · A2DHMW

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

China Resources Medical Holdings Company Margin History

China Resources Medical Holdings Company Stock Sales Revenue, EBIT, Earnings per Share KYG2133W1087 · A2DHMW

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

China Resources Medical Holdings Company Revenue, EBIT and net profit per share

China Resources Medical Holdings Company business model

China Resources Medical Holdings Company SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

China Resources Medical Holdings Company Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

China Resources Medical Holdings Company historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

China Resources Medical Holdings Company shares outstanding KYG2133W1087 · A2DHMW

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

China Resources Medical Holdings Company dividend history and estimates KYG2133W1087 · A2DHMW

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

China Resources Medical Holdings Company Dividend History

Ticker
1515.HK

ISIN
KYG2133W1087

WKN
A2DHMW